Logo image of ARWR

ARROWHEAD PHARMACEUTICALS IN (ARWR) Stock Analyst Earnings Estimates

NASDAQ:ARWR - Nasdaq - US04280A1007 - Common Stock - Currency: USD

16.47  +0 (+0.03%)

After market: 16.79 +0.32 (+1.94%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ARWR revenue by date.ARWR revenue by date.
243.2M
75.85%
240.7M
-1.03%
3.551M
-98.52%
798.44M
22,384.93%
319.07M
-60.04%
373.27M
16.99%
418.12M
12.02%
843.01M
101.62%
1.571B
86.36%
2.224B
41.57%
2.876B
29.32%
EBITDA
YoY % growth
ARWR ebitda by date.ARWR ebitda by date.
-168.1M
-19.47%
-192.5M
-14.52%
-582.485M
-202.59%
-132.086M
77.32%
-400.71M
-203.37%
-563.814M
-40.70%
-465.12M
17.50%
-174.012M
62.59%
393.72M
326.26%
N/AN/A
EBIT
YoY % growth
ARWR ebit by date.ARWR ebit by date.
-178.5M
-19.80%
-205M
-14.85%
-601.08M
-193.21%
171.3M
128.50%
-460.844M
-369.03%
-559.643M
-21.44%
-395.107M
29.40%
-69.931M
82.30%
589.78M
943.37%
1.115B
89.05%
1.658B
48.70%
Operating Margin
ARWR operating margin by date.ARWR operating margin by date.
-73.40%-85.17%-16,927.06%21.45%-144.43%-149.93%-94.50%-8.30%37.54%50.13%57.65%
EPS
YoY % growth
ARWR eps by date.ARWR eps by date.
-1.68
-23.53%
-1.92
-14.29%
-5.01
-160.94%
0.04
100.84%
-3.43
-8,210.78%
-3.68
-7.23%
-2.72
25.96%
-0.02
99.25%
5.00
24,600.00%
12.97
159.59%
18.79
44.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.05
24.23%
-0.38
71.94%
-0.41
70.65%
-1.26
-145.70%
-1.21
-16.09%
-1.21
-215.73%
Revenue
Q2Q % growth
24.185M212.72M180.17M
7,106.80%
30.409M
-94.40%
24.99M
3.33%
25.5M
-88.01%
EBITDA
Q2Q % growth
-99.616M
38.72%
-135.663M
5.53%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-141.169M
19.85%
-52.014M
67.93%
-71.038M
55.99%
-158.219M
-141.51%
-152.593M
-8.09%
-152.601M
-193.38%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
2.75
369.61%
-0.202.951,461.66%
Q1 2025
Q2Q % growth
-1.39
-12.10%
-0.45-0.94-211.36%
Q4 2024
Q2Q % growth
-1.37
-34.31%
-1.07-0.30-28.19%
Q3 2024
Q2Q % growth
-1.38
-43.75%
-0.56-0.82-145.24%
Q2 2024
Q2Q % growth
-1.02
-326.67%
-0.17-0.85-515.69%
Q1 2024
Q2Q % growth
-1.24
-217.95%
-0.84-0.40-48.25%
Q4 2023
Q2Q % growth
-1.02
-25.93%
-0.62-0.40-65.77%
Q3 2023
Q2Q % growth
-0.96
-41.18%
-0.67-0.29-44.13%
Q2 2023
Q2Q % growth
0.45
9.76%
-0.651.10168.84%
Q1 2023
Q2Q % growth
-0.39
35.00%
0.45-0.84-187.62%
Q4 2022
Q2Q % growth
-0.81
-32.79%
-0.17-0.64-379.95%
Q3 2022
Q2Q % growth
-0.68
-134.48%
-0.52-0.16-31.80%
Q2 2022
Q2Q % growth
0.41
257.69%
-0.080.49596.25%
Q1 2022
Q2Q % growth
-0.60
-200.00%
-0.46-0.14-31.60%
Q4 2021
Q2Q % growth
-0.61
-27.08%
-0.11-0.50-467.08%
Q3 2021
Q2Q % growth
-0.29
-123.08%
-0.20-0.09-44.10%
Q2 2021
Q2Q % growth
-0.26
-30.00%
-0.13-0.13-94.14%
Q1 2021
Q2Q % growth
-0.20
-566.67%
0.12-0.32-266.32%
Q4 2020
Q2Q % growth
-0.48
-536.36%
0.12-0.60-504.42%
Q3 2020
Q2Q % growth
-0.13
-161.90%
-0.12-0.01-9.87%
Q2 2020
Q2Q % growth
-0.20
-183.33%
-0.11-0.09-80.07%
Q1 2020
Q2Q % growth
-0.03
-123.08%
-0.01-0.02-311.93%
Q4 2019
Q2Q % growth
0.11 0.17-0.06-34.36%
Q3 2019
Q2Q % growth
0.21 0.30-0.09-29.81%
Q2 2019
Q2Q % growth
0.24 0.200.0421.71%
Q1 2019
Q2Q % growth
0.13 0.55-0.42-76.32%
ARWR Yearly EPS VS EstimatesARWR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
543M 30.504M512.496M1,680.09%
Q1 2025
Q2Q % growth
2.5M
-29.60%
74.205M-71.705M-96.63%
Q4 2024
Q2Q % growth

-100.00%
65.099M-65.099M-100.00%
Q3 2024
Q2Q % growth

-100.00%
53.688M-53.688M-100.00%
Q2 2024
Q2Q % growth

-100.00%
65.147M-65.147M-100.00%
Q1 2024
Q2Q % growth
3.551M
-94.32%
30.101M-26.55M-88.20%
Q4 2023
Q2Q % growth
16.097M
-49.06%
51.743M-35.646M-68.89%
Q3 2023
Q2Q % growth
15.825M
-51.16%
50.169M-34.344M-68.46%
Q2 2023
Q2Q % growth
146.267M
-3.64%
46.389M99.878M215.31%
Q1 2023
Q2Q % growth
62.5M
128.10%
165.77M-103.27M-62.30%
Q4 2022
Q2Q % growth
31.6M
-17.49%
51.453M-19.853M-38.58%
Q3 2022
Q2Q % growth
32.4M
-29.41%
56.332M-23.932M-42.48%
Q2 2022
Q2Q % growth
151.8M
362.80%
111.09M40.71M36.65%
Q1 2022
Q2Q % growth
27.4M
28.64%
52.065M-24.665M-47.37%
Q4 2021
Q2Q % growth
38.3M
403.95%
57.91M-19.61M-33.86%
Q3 2021
Q2Q % growth
45.9M
67.52%
38.267M7.633M19.95%
Q2 2021
Q2Q % growth
32.8M
39.57%
38.451M-5.651M-14.70%
Q1 2021
Q2Q % growth
21.3M
-27.80%
77.076M-55.776M-72.36%
Q4 2020
Q2Q % growth
7.6M
-82.45%
50.227M-42.627M-84.87%
Q3 2020
Q2Q % growth
27.4M
-35.83%
29.49M-2.09M-7.09%
Q2 2020
Q2Q % growth
23.5M
-51.14%
22.175M1.325M5.98%
Q1 2020
Q2Q % growth
29.5M
-14.99%
30.09M-590K-1.96%
Q4 2019
Q2Q % growth
43.3M 42.311M989K2.34%
Q3 2019
Q2Q % growth
42.7M 55.454M-12.754M-23.00%
Q2 2019
Q2Q % growth
48.1M 43.848M4.252M9.70%
Q1 2019
Q2Q % growth
34.7M 73.032M-38.332M-52.49%
ARWR Yearly Revenue VS EstimatesARWR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -13.03% 0% 101.14%
Revenue0% -47.98% 2.09% 401.85%